484 related articles for article (PubMed ID: 15921890)
1. A comparison of brachytherapy and surgery for the treatment of stage I-II squamous cell carcinoma of the tongue.
Umeda M; Komatsubara H; Ojima Y; Minamikawa T; Shibuya Y; Yokoo S; Ishii J; Komori T
Int J Oral Maxillofac Surg; 2005 Oct; 34(7):739-44. PubMed ID: 15921890
[TBL] [Abstract][Full Text] [Related]
2. High-dose rate interstitial brachytherapy for stage I-II tongue cancer.
Umeda M; Komatsubara H; Nishimatsu N; Yokoo S; Shibuya Y; Komori T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):667-70. PubMed ID: 11077395
[TBL] [Abstract][Full Text] [Related]
3. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
[TBL] [Abstract][Full Text] [Related]
4. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
5. Treatment results and prognostic factors in oral tongue cancer: analysis of 80 patients.
Aksu G; Karadeniz A; Saynak M; Fayda M; Kadehci Z; Kocaelli H
Int J Oral Maxillofac Surg; 2006 Jun; 35(6):506-13. PubMed ID: 16503396
[TBL] [Abstract][Full Text] [Related]
6. Is glossectomy necessary for late nodal metastases without clinical local recurrence after initial brachytherapy for N0 tongue cancer? A retrospective experience in 111 patients who received salvage therapy for cervical failure.
Urashima Y; Nakamura K; Kunitake N; Shioyama Y; Sasaki T; Ooga S; Kuratomi Y; Yamamoto T; Kawazu T; Chikui T; Jingu K; Terashima H; Honda H
Jpn J Clin Oncol; 2006 Jan; 36(1):3-6. PubMed ID: 16418183
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological presentation of tongue cancers and early cancer treatment.
Najeeb T
J Coll Physicians Surg Pak; 2006 Mar; 16(3):179-82. PubMed ID: 16542596
[TBL] [Abstract][Full Text] [Related]
8. The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis.
Takácsi-Nagy Z; Oberna F; Polgár C; Somogyi A; Major T; Németh G
Neoplasma; 2001; 48(1):76-81. PubMed ID: 11327543
[TBL] [Abstract][Full Text] [Related]
9. [Results of stage I and II tongue squamous cell carcinomas treated with different modalities].
Chang-Ming A; Bin Z; Zhen-Gang X; Ping-Zhang T
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):302-5. PubMed ID: 18788638
[TBL] [Abstract][Full Text] [Related]
10. Radical radiotherapy compared with surgery for advanced squamous cell carcinoma of the base of tongue.
van de Pol M; Levendag PC; de Bree RR; Franssen JH; Smeele LE; Nijdam WM; Jansen PP; Meeuwis CA; Leemans CR
Brachytherapy; 2004; 3(2):78-86. PubMed ID: 15374539
[TBL] [Abstract][Full Text] [Related]
11. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
[TBL] [Abstract][Full Text] [Related]
12. Curative brachytherapy for recurrent/residual tongue cancer.
Ayukawa F; Shibuya H; Yoshimura R; Watanabe H; Miura M
Strahlenther Onkol; 2007 Mar; 183(3):133-7. PubMed ID: 17340071
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix.
Tanaka E; Oh RJ; Yamada Y; Shiomi H; Nakamura S; Shimamoto S; Teshima T; Inoue T; Inoue T
Brachytherapy; 2003; 2(2):85-90. PubMed ID: 15062145
[TBL] [Abstract][Full Text] [Related]
14. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
[TBL] [Abstract][Full Text] [Related]
15. Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.
Lim YC; Lee JS; Koo BS; Kim SH; Kim YH; Choi EC
Laryngoscope; 2006 Mar; 116(3):461-5. PubMed ID: 16540910
[TBL] [Abstract][Full Text] [Related]
16. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E
Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival.
Narayan K; van Dyk S; Bernshaw D; Rajasooriyar C; Kondalsamy-Chennakesavan S
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1529-35. PubMed ID: 19473780
[TBL] [Abstract][Full Text] [Related]
18. Treatment results of stage I oral tongue cancer with definitive radiotherapy.
Ichimiya Y; Fuwa N; Kamata M; Kodaira T; Furutani K; Tachibana H; Tomita N; Hidano S
Oral Oncol; 2005 May; 41(5):520-5. PubMed ID: 15878758
[TBL] [Abstract][Full Text] [Related]
19. High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 2. Phase III trial of HDR versus LDR interstitial brachytherapy for T1-T2N0 carcinoma of the mobile tongue.
Inoue T; Inoue T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():291-5. PubMed ID: 10895169
[No Abstract] [Full Text] [Related]
20. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
